Table 3 Open in new tab Univariable and...

	Univariate	Multivariate
Age	1.04 (1.03–1.06)	<0.01	1.05 (1.02–1.07)	<0.01
Sex	1.18 (0.83–1.69)	0.35
Hypertension	1.62 (1.05–2.50)	0.03	1.09 (0.69–1.73)	0.70
Diabetes mellitus	1.52 (1.07–2.17)	0.02	1.33 (0.91–1.96)	0.15
Dyslipidaemia	0.94 (0.66–1.34)	0.94
Prior stroke	1.01 (0.51–1.99)	0.97
Prior MI	1.26 (0.82–1.91)	0.29
CKD >2	1.63 (1.13–2.35)	0.01	1.03 (0.68–1.57)	0.88
EuroSCORE II	1.04 (1.03–1.05)	<0.01	1.05 (1.03–1.05)	<0.01
STEMI presentation	1.08 (0.60–1.96)	0.80
Involved vall—anterior	1.58 (1.09–2.30)	0.06	1.03 (0.69–1.53)	0.90
Killip class ≥3	2.24 (1.54–3.25)	<0.01	2.31 (1.42–3.74)	<0.01
Multivessel CAD	1.17 (0.80–1.71)	0.41
PCI	0.75 (0.51–1.11)	0.15
LVEF	0.97 (0.96–0.99)	<0.01	0.974 (0.98–1.01)	0.71
Mechanical ventilation	2.27 (1.56–3.31)	<0.01	Represented in Killip
Cardiogenic shock	3.04 (2.13–4.35)	<0.01	Represented in Killip
Any MCS	1.38 (0.93–2.04)	0.11	2.12 (1.28–3.50)	<0.01
Any intervention	0.37 (0.25–0.56)	<0.01	0.26 (0.17–0.45)	<0.01

Univariate

Multivariate

Variable

HR (95% CI)

P-value

HR (95% CI)

P-value

Age

1.04 (1.03–1.06)

<0.01

1.05 (1.02–1.07)

<0.01

Sex

1.18 (0.83–1.69)

0.35

Hypertension

1.62 (1.05–2.50)

0.03

1.09 (0.69–1.73)

0.70

Diabetes mellitus

1.52 (1.07–2.17)

0.02

1.33 (0.91–1.96)

0.15

Dyslipidaemia

0.94 (0.66–1.34)

0.94

Prior stroke

1.01 (0.51–1.99)

0.97

Prior MI

1.26 (0.82–1.91)

0.29

CKD >2

1.63 (1.13–2.35)

0.01

1.03 (0.68–1.57)

0.88

EuroSCORE II

1.04 (1.03–1.05)

<0.01

1.05 (1.03–1.05)

<0.01

STEMI presentation

1.08 (0.60–1.96)

0.80

Involved vall—anterior

1.58 (1.09–2.30)

0.06

1.03 (0.69–1.53)

0.90

Killip class ≥3

2.24 (1.54–3.25)

<0.01

2.31 (1.42–3.74)

<0.01

Multivessel CAD

1.17 (0.80–1.71)

0.41

PCI

0.75 (0.51–1.11)

0.15

LVEF

0.97 (0.96–0.99)

<0.01

0.974 (0.98–1.01)

0.71

Mechanical ventilation

2.27 (1.56–3.31)

<0.01

Represented in Killip

Cardiogenic shock

3.04 (2.13–4.35)

<0.01

Represented in Killip

Any MCS

1.38 (0.93–2.04)

0.11

2.12 (1.28–3.50)

<0.01

Any intervention

0.37 (0.25–0.56)

<0.01

0.26 (0.17–0.45)

<0.01

	Univariate	Multivariate
Age	1.04 (1.03–1.06)	<0.01	1.05 (1.02–1.07)	<0.01
Sex	1.18 (0.83–1.69)	0.35
Hypertension	1.62 (1.05–2.50)	0.03	1.09 (0.69–1.73)	0.70
Diabetes mellitus	1.52 (1.07–2.17)	0.02	1.33 (0.91–1.96)	0.15
Dyslipidaemia	0.94 (0.66–1.34)	0.94
Prior stroke	1.01 (0.51–1.99)	0.97
Prior MI	1.26 (0.82–1.91)	0.29
CKD >2	1.63 (1.13–2.35)	0.01	1.03 (0.68–1.57)	0.88
EuroSCORE II	1.04 (1.03–1.05)	<0.01	1.05 (1.03–1.05)	<0.01
STEMI presentation	1.08 (0.60–1.96)	0.80
Involved vall—anterior	1.58 (1.09–2.30)	0.06	1.03 (0.69–1.53)	0.90
Killip class ≥3	2.24 (1.54–3.25)	<0.01	2.31 (1.42–3.74)	<0.01
Multivessel CAD	1.17 (0.80–1.71)	0.41
PCI	0.75 (0.51–1.11)	0.15
LVEF	0.97 (0.96–0.99)	<0.01	0.974 (0.98–1.01)	0.71
Mechanical ventilation	2.27 (1.56–3.31)	<0.01	Represented in Killip
Cardiogenic shock	3.04 (2.13–4.35)	<0.01	Represented in Killip
Any MCS	1.38 (0.93–2.04)	0.11	2.12 (1.28–3.50)	<0.01
Any intervention	0.37 (0.25–0.56)	<0.01	0.26 (0.17–0.45)	<0.01

Table 3

Open in new tab

Univariable and multivariable model, 1 year

	Univariate		Multivariate
Variable	HR (95% CI)	P-value	HR (95% CI)	P-value
Age	1.04 (1.03–1.06)	<0.01	1.05 (1.02–1.07)	<0.01
Sex	1.18 (0.83–1.69)	0.35
Hypertension	1.62 (1.05–2.50)	0.03	1.09 (0.69–1.73)	0.70
Diabetes mellitus	1.52 (1.07–2.17)	0.02	1.33 (0.91–1.96)	0.15
Dyslipidaemia	0.94 (0.66–1.34)	0.94
Prior stroke	1.01 (0.51–1.99)	0.97
Prior MI	1.26 (0.82–1.91)	0.29
CKD >2	1.63 (1.13–2.35)	0.01	1.03 (0.68–1.57)	0.88
EuroSCORE II	1.04 (1.03–1.05)	<0.01	1.05 (1.03–1.05)	<0.01
STEMI presentation	1.08 (0.60–1.96)	0.80
Involved vall—anterior	1.58 (1.09–2.30)	0.06	1.03 (0.69–1.53)	0.90
Killip class ≥3	2.24 (1.54–3.25)	<0.01	2.31 (1.42–3.74)	<0.01
Multivessel CAD	1.17 (0.80–1.71)	0.41
PCI	0.75 (0.51–1.11)	0.15
LVEF	0.97 (0.96–0.99)	<0.01	0.974 (0.98–1.01)	0.71
Mechanical ventilation	2.27 (1.56–3.31)	<0.01	Represented in Killip
Cardiogenic shock	3.04 (2.13–4.35)	<0.01	Represented in Killip
Any MCS	1.38 (0.93–2.04)	0.11	2.12 (1.28–3.50)	<0.01
Any intervention	0.37 (0.25–0.56)	<0.01	0.26 (0.17–0.45)	<0.01

	Univariate		Multivariate
Variable	HR (95% CI)	P-value	HR (95% CI)	P-value
Age	1.04 (1.03–1.06)	<0.01	1.05 (1.02–1.07)	<0.01
Sex	1.18 (0.83–1.69)	0.35
Hypertension	1.62 (1.05–2.50)	0.03	1.09 (0.69–1.73)	0.70
Diabetes mellitus	1.52 (1.07–2.17)	0.02	1.33 (0.91–1.96)	0.15
Dyslipidaemia	0.94 (0.66–1.34)	0.94
Prior stroke	1.01 (0.51–1.99)	0.97
Prior MI	1.26 (0.82–1.91)	0.29
CKD >2	1.63 (1.13–2.35)	0.01	1.03 (0.68–1.57)	0.88
EuroSCORE II	1.04 (1.03–1.05)	<0.01	1.05 (1.03–1.05)	<0.01
STEMI presentation	1.08 (0.60–1.96)	0.80
Involved vall—anterior	1.58 (1.09–2.30)	0.06	1.03 (0.69–1.53)	0.90
Killip class ≥3	2.24 (1.54–3.25)	<0.01	2.31 (1.42–3.74)	<0.01
Multivessel CAD	1.17 (0.80–1.71)	0.41
PCI	0.75 (0.51–1.11)	0.15
LVEF	0.97 (0.96–0.99)	<0.01	0.974 (0.98–1.01)	0.71
Mechanical ventilation	2.27 (1.56–3.31)	<0.01	Represented in Killip
Cardiogenic shock	3.04 (2.13–4.35)	<0.01	Represented in Killip
Any MCS	1.38 (0.93–2.04)	0.11	2.12 (1.28–3.50)	<0.01
Any intervention	0.37 (0.25–0.56)	<0.01	0.26 (0.17–0.45)	<0.01

CAD, coronary artery disease; CKD, chronic kidney disease; EuroSCORE II, European System for Cardiac Operative Risk Evaluation; LVEF, left ventricular ejection fraction; MI, myocardial infarction; MCS, mechanical circulatory support; PCI, percutaneous coronary intervention; PMVR, percutaneous mitral valve repair; SMVR, surgical mitral valve repair or replacement; STEMI, ST-elevation myocardial infarction. Values in bold are statistically significant p-values.

This Feature Is Available To Subscribers Only